Condition: Advanced Non-squamous Non-small-cell Lung Cancer · Advanced Squamous Non-Small Cell Lung Carcinoma · Metastatic Non-squamous Non Small Cell Lung Cancer · Sponsor: Genelux Corporation
This Phase 2, open-label, randomized study in non-small-cell lung cancer (NSCLC) is designed to evaluate the efficacy and safety of an intravenously delivered oncolytic vaccinia virus, Olvi-Vec, followed by platinum-doublet chemotherapy + Physician's Choice of Immune Checkpoint Inhibitor (ICI) vs. docetaxel for patients with advanced or metastatic NSCLC who have shown first disease progression (i.e., progressive disease not yet confirmed by further scan after initial scan showing progression) while on front-line treatment or maintenance ICI therapy after front-line treatment with platinum-doublet chemotherapy + ICI as standard of care.
This description comes directly from the study's public registry record.
Contact details are listed per location below or on the registry record.
Always discuss trial participation with your own doctor first.
| Pioneer Research Center, LLC | Bullhead City, Arizona, United States | Recruiting |
| Clermont Oncology Center | Clermont, Florida, United States | Recruiting |
| Oncology & Hematology Associates of West Broward | Coral Springs, Florida, United States | Recruiting |
| Helios Clinical Research | Fort Lauderdale, Florida, United States | Recruiting |
| Bioresearch Partner | Hialeah, Florida, United States | Recruiting |
| University of Miami - Sylvester Comprehensive Cancer Center | Miami, Florida, United States | Recruiting |
| Bioresearch Partner | Miami, Florida, United States | Recruiting |
| Mid Florida Hematology and Oncology Center | Orange City, Florida, United States | Recruiting |
| BRCR Medical Center, Inc. | Plantation, Florida, United States | Recruiting |
| Michigan Hematology and Oncology Consultants | Dearborn, Michigan, United States | Recruiting |
| Oakland Medical Group | Farmington Hills, Michigan, United States | Recruiting |
| Inspira Medical Center Mullica Hill | Mullica Hill, New Jersey, United States | Recruiting |
+ 3 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06463665